The Effect of Su-jok Therapy Applied in the First Stage of Labor on Pain Level in Primiparas

December 30, 2024 updated by: AYSUDA REFİYE AKVERAN, Hitit University
The aim of this study is to examine the effect of sujok therapy applied in the first stage of labor on the pain level in primiparas.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Birth pain, known as acute pain, is felt in the human body as one of the oldest, complex, severe and most difficult to control types of pain. However, this pain differs from other types of pain due to the fact that it reunites the mother with her baby and covers a limited period of time. Pain is a subjective phenomenon that every individual experiences throughout their lives and to which people react differently.

Su Jok therapy, an alternative and complementary therapy technique, is seen as a method that balances the energy flow based on the philosophy of non-pharmacological and non-invasive acupuncture that can be used to control labor pain.

Su-jok application is the development of a massage therapy that will create a feeling of comfort in the body by using certain points. There are tiny swellings on the reflection points on the hands and feet (such as the area between the 3rd and 4th fingers reflecting the uterus area). These are also called micro acupuncture points. When pressure is applied to these swellings on the hands and feet for 1-2 minutes, pain and a feeling of pulling occur. Thus, the area to be massaged is determined. During the detection phase, a blunt-tipped diagnostic probe or a round-tipped stick can be used. At this stage, the same amount of pressure should be applied to the area to be applied. When a point is determined, the correct point for massage application should be massaged and energy flow should be provided. Since it does not have any side effects, it is a therapy that can be used in pregnant women and is a massage application that does not require any invasive intervention.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Merkez
      • Çorum, Merkez, Turkey, 19000

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being primiparous
  • The pregnant woman must be over 18 years of age
  • To participate in the research voluntarily
  • The beginning of labor (water breaking, presence of non-stress testa contractions, engagement)

Exclusion Criteria:

  • Pregnancies outside 37-41 weeks
  • Multiparas
  • Those who are not pregnant
  • Having visual, mental and auditory disabilities
  • Being pregnant as an adolescent
  • Not accepting participation in the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Su jok therapy group
Sujok massage therapy will be applied to the affected area on the hands of pregnant women who will give birth for the first time.
The researcher, who has a Su-Jok practitioner certificate, applied pressure for 1-2 minutes on the active point on the meridian (the area between the 3rd and 4th fingers pointing to the uterus) that provides energy flow in the palm in 20-minute periods, with the help of a diagnostic probe (diagnostic stick). The point will be determined. Once this point is detected, a massage will be performed on the point. The massage will be applied with a 10-minute rest period between each two periods.
No Intervention: Control Group
A comparison will be made on this group with pregnant women who receive sujok therapy without any therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS)
Time Frame: eight months
A number indicating the pain level will be expressed on the scale between 1-10.
eight months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MONITORING FORM FOR BIRTH (FOR SU JOK GROUP)
Time Frame: eight months
It is a survey that includes pregnant women's information about birth and their opinions on su jok therapy.
eight months
MONITORING FORM FOR BIRTH (CONTROL GROUP)
Time Frame: eight months
The survey, which consists of nine questions, includes information about the birth process of pregnant women. (Vitals, vaginal examination findings)
eight months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 15, 2025

Primary Completion (Estimated)

August 15, 2025

Study Completion (Estimated)

August 30, 2025

Study Registration Dates

First Submitted

December 30, 2024

First Submitted That Met QC Criteria

December 30, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 30, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HU-SBF-ARA-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Pain

Clinical Trials on Su Jok Therapy

Subscribe